CNS Pharmaceuticals (CNSP) Assets (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Assets came in at $8.6 million in Q4 2025, down 0.89% YoY from $8.7 million in Q4 2024, and down 27.35% on a QoQ basis from $11.9 million in Q3 2025.
CNS Pharmaceuticals (CNSP) Assets (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Assets data on file, last reported at $8.6 million in Q4 2025.
- Quarterly Assets fell 0.89% year-over-year to $8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (down 0.89% YoY) and the FY2025 annual result came in at $8.6 million, down 0.89% from the prior year.
- Assets declined to $8.6 million in Q4 2025, from $11.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $15.9 million in Q1 2022 to a low of $1.7 million in Q1 2024.
- A 5-year average of $9.3 million and a median of $9.2 million in 2021 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets slumped 86.97% — and 2025, when it soared 727.83%.
- Tracing CNSP's Assets over 5 years: stood at $8.8 million in 2021, then jumped by 49.05% to $13.1 million in 2022, then tumbled by 86.97% to $1.7 million in 2023, then surged by 411.56% to $8.7 million in 2024, then declined by 0.89% to $8.6 million in 2025.
- The last three Assets figures came in at $8.6 million (Q4 2025), $11.9 million (Q3 2025), and $14.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - | 8.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 14.51 Mn |
| Mar 31, 2025 | 13.75 Mn |
| Dec 31, 2024 | 8.70 Mn |
| Sep 30, 2024 | 7.41 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 2.33 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 7.41 Mn |
| Dec 31, 2022 | 13.05 Mn |
| Sep 30, 2022 | 9.64 Mn |
| Jun 30, 2022 | 12.45 Mn |
| Mar 31, 2022 | 15.87 Mn |
| Dec 31, 2021 | 8.76 Mn |
| Sep 30, 2021 | 11.51 Mn |
| Jun 30, 2021 | 14.24 Mn |
| Mar 31, 2021 | 13.14 Mn |